April 7 (Reuters) - Odi Pharma AB (publ) ODI.TE :
* STATUS UPDATE IN CONNECTION TO COVID-19
* BOARD OF DIRECTORS DOES NOT SEE ANY IMPACT ON COMPANY'S
MID- AND
LONG-TERM GOALS DUE TO COVID-19
* ODI PHARMA- ODI DOES NOT SEE ANY IMPACT ON MID- AND
LONG-TERM
GOALS FOLLOWING COVID-19
* BOARD OF DIRECTORS AND MANAGEMENT CURRENTLY FORECAST A
DELAY OF
FIRST SALES OF PRODUCT BY APPROXIMATELY THREE MONTHS.
* FORECAST A DELAY OF FIRST SALES OF PRODUCT BY
APPROXIMATELY
THREE MONTHS
Source text for Eikon: ID:nWkr2F0gDT
Further company coverage: ODI.TE
((Reuters.Briefs@thomsonreuters.com;))